LifeScan

Medical equipment company

LifeScan, Inc.Industry| Medical devices

|

Founded| 1981; 44 years ago (1981)
Headquarters|

Malvern, Pennsylvania and Zug, Switzerland

Area served

| Global
Revenue| US$1.5 billion (2017)[1]

Number of employees

| 2,400(2020)[2]
Parent| Platinum Equity

LifeScan, Inc. is a diagnostic systems manufacturer with products focusing on the diabetes market, specifically blood glucose monitoring systems.

## History

[edit]

LifeScan was established in 1981.[3] It was acquired by Johnson & Johnson (J&J) in 1986,[2][4] and in June 2018, J&J agreed to sell LifeScan to Platinum Equity as part of its strategic exit from the diabetes device market, accepting an offer originally tendered in March 2018.[1] The divestiture completed in October 2018.[1][5]

LifeScan manufactures and markets the OneTouch Ultra and OneTouch Verio families of products for home use.[1] The company philosophy is to "create a world without limits for people with diabetes." During its existence, LifeScan revolutionized blood glucose monitoring by introduction of its "One Touch" systems. Originally, the measurement was made using a test strip which changed color depending on the glucose content of a blood sample, and LifeScan rose to become the world-leading producer of such systems in the early 1990s. Later, the measurement technology was changed to electrochemistry, but LifeScan maintained a leading position in the industry.

LifeScan has facilities in Inverness, Scotland; Burnaby, British Columbia, Canada; and Cabo Rojo, Puerto Rico. Animas Corporation of West Chester, Pennsylvania, which produced insulin pumps for people with diabetes, was acquired by Johnson & Johnson in 2006 and now closed, reported to LifeScan.

LifeScan, which employed 2400 people as of early 2018, was the central part of J&J's diabetes device business.[2] J&J announced plans to exit from the diabetes device market in 2017, including divesting LifeScan.[2] In January 2018, there were reports of Chinese investors expressing interest in purchasing the company for US$3 to 4 billion, while in March, Platinum Equity offered the far smaller sum of US$2.1 billion for the unit.[2][6]

## References

[edit]

1. ^ a b c d Nawrat, Allie (June 15, 2018). "Johnson & Johnson sells LifeScan to Platinum Equity". Pharmaceutical Technology. Verdict Media Limited. Retrieved June 16, 2018.
2. ^ a b c d e Panchadar, Arjun (16 March 2018). "Johnson & Johnson nears diabetes device exit with $2.1 billion LifeScan sale". Reuters. Additional reporting by Caroline Humer and Munsif Vengattil; S D'Souza, P Berlowitz (editors). Retrieved 17 March 2018.
3. ^ "LifeScan Inc - Company Profile and News". Bloomberg.com. Retrieved 30 April 2024.
4. ^ About Us | LifeScan, Inc." LifeScan. Retrieved on September 18, 2014.
5. ^ LaVito, Angelica (October 16, 2018). "Johnson & Johnson beats expectations as cancer drugs, new baby care products help boost sales". CNBC.
6. ^ "Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc". Content Lab - U.S. 16 March 2018.

## External links

[edit]

* Companies portal

* LifeScan
* LifeScan Diabetes Institute
* OneTouch

* v
* t
* e

Johnson & Johnson

Product
brands|

| Innovative medicine|

* Balversa
* Concerta
* Darzalex
* Ditropan
* Duragesic
* Edurant
* Elmiron
* Erleada
* Haldol
* Imbruvica
* Intelence
* Invega
* Invokamet
* Invokana
* Prezcobix
* Prezista
* Procrit
* Razadyne
* Remicade
* Risperdal
* Simponi
* Sirturo
* Sporanox
* Spravato
* Stelara
* Symtuza
* Talvey
* Tecvayli
* Terazol
* Topamax
* Tremfya
* Ultracet
* Ultram
* Vermox
* Xarelto
* Yondelis
* Zytiga
* Opsumit
* Tracleer
* Zavesca
* Uptravi
* Veletri
* Vintivis
* Vermax

|

Medtech|

* Acuvue
* Ethilon
* Vicryl
* Prolene
* Monocryl
* Dermabond

Companies|

| Subsidiaries|

| Innovative medicine|

* Actelion
* Alza
* Cilag
* Janssen Vaccines
* Janssen Pharmaceuticals
* MorphoSys
* Ortho-McNeil Pharmaceutical
* Ortho-McNeil-Janssen
* Ortho Pharmaceutical
* Tibotec
* Johnson & Johnson Pharmaceutical Research and Development

|

Medtech|

* DePuy Synthes
* Ethicon Inc.
* Johnson & Johnson Vision
* Mentor (company)

Acquisitions|

* Abiomed
* Puma Biotechnology
* Technicare

Partnerships|

* IBOT

People|

| Executives and scientists|

* Joaquin Duato (Chairman and CEO)

|

Board of directors|

* Joaquin Duato
* Darius Adamczyk
* Mary C. Beckerle
* Jennifer A. Doudna
* Marillyn A. Hewson
* Paula A. Johnson
* Hubert Joly
* Mark B. McClellan
* Anne M. Mulcahy
* Mark A. Weinberger
* Nadja Y. West

Founders|

* Robert Wood Johnson I
* James Wood Johnson
* Edward Mead Johnson
* George J. Seabury

Former executives,
board members,
and scientists|

* Koen Andries
* James Arthur Bayton
* David S. Bredt
* Mary Sue Coleman
* Joan Ganz Cooney
* Robert J. Darretta Jr.
* Russell Deyo
* Leopoldo Fernández Pujals
* Peter Goodhand
* Jaap Goudsmit
* Marillyn Hewson
* Robert Wood Johnson II
* Robert Wood Johnson III
* Duda Kertész
* Frederick Barnett Kilmer
* Robert Q. Marston
* Cynthia A. Maryanoff
* Sheri McCoy
* Boyd Melson
* Indra Nooyi
* Bill Osborn
* Miguel Patricio
* William D. Perez
* Sandi Peterson
* Christine Poon
* Larry Probst
* A. V. Gurava Reddy
* Steven Reinemund
* Duane J. Roth
* David Satcher
* George J. Seabury
* Nancy Snyderman
* William C. Weldon
* Ron Williams
* Ronald A. Williams
* Dick Zimmer
* D. Scott Davis

Former
subsidiaries|

* LifeScan
* Ortho Clinical Diagnostics
* Tasmanian Alkaloids

Legacy
brands|

* Abciximab
* Actifed
* Axert
* Bactidol
* Bapineuzumab
* Benecol (US license)
* Benylin
* Caladryl
* Cyclobenzaprine
* Carefree (feminine hygiene)
* Cetirizine
* Doripenem
* Eluxadoline
* Carisbamate
* Carlumab
* Cladribine
* Combantrin
* Doxil
* Doxorubicin
* Euthymol
* Fulranumab
* Helioplex
* Hydromorphone
* JNJ-26489112
* JNJ-26990990
* JNJ-5207852
* JNJ-39393406
* JNJ-7925476
* Emtricitabine/rilpivirine/tenofovir
* K-Y Jelly
* Levaquin
* Lomotil
* Loperamide
* McN5652
* Methylphenidate
* Ofloxacin
* Opsumit
* Micronor
* Mylanta
* Mylicon
* Natrecor
* Nizoral
* Neomycin/polymyxin B/bacitracin
* o.b.
* OneTouch Ultra
* Ortho Tri-Cyclen
* Ortho-Cyclen
* Ortho-Novum
* Pancreatic
* Prucalopride
* Quisinostat
* Rabeprazole
* Reach (brand)
* Rembrandt toothpaste
* Rolaids
* RWJ-51204
* Savlon
* Sinutab
* Splenda
* Sylvant
* Telaprevir
* Tipifarnib

Buildings|

* Johnson and Johnson Plaza

Related|

* 2010 DePuy Hip Recall
* 2010 Johnson & Johnson children's product recall
* 5B (film)
* Born Rich (2003 film)
* Chicago Tylenol murders
* Dr. Paul Janssen Award for Biomedical Research
* Global Health Innovative Technology Fund (GHIT)
* Innerstate
* Robert Wood Johnson Foundation
* Steve Patterson Award for Excellence in Sports Philanthropy
* Tooth Protectors
* YODA Project

Authority control databases

International|

* ISNI
* VIAF

National|

* United States

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template